Skip to main content
Medical information Clinical review pending

Neurology

Autoimmune Cerebellar Ataxia Panel Test

This test helps diagnose autoimmune disorders affecting the cerebellum, which controls balance and coordination. It identifies specific antibodies linked to these conditions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (1.5 mL minimum) serum collected in an SST tube.
Results
Confirm with the laboratory before booking.
Preparation
Overnight fasting is preferred. A completed Test Send Out Consent Form (Form 35) is required.
Test priceKSh 200,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Autoimmune Cerebellar Ataxia Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained balance problems
  • ✓Frequent falls or unsteadiness
  • ✓Dizziness or vertigo
  • ✓Difficulty with coordination
  • ✓Neurological symptoms without a clear cause
  • ✓Suspected autoimmune neurological disorder
02

In plain language

What this test helps you understand

This test aids in the diagnosis of autoimmune conditions affecting the cerebellum, helping to identify the specific antibodies involved. This information is crucial for guiding treatment decisions and managing patient care.
The Autoimmune Cerebellar Ataxia Panel Test is a specialized diagnostic tool used to identify autoimmune disorders that impact the cerebellum, the part of the brain responsible for coordination and balance. This test is particularly important for individuals experiencing symptoms like unsteady gait, dizziness, and coordination difficulties. It provides crucial information to help healthcare providers determine the cause of these symptoms and plan appropriate treatment.

This panel test looks for several specific antibodies associated with autoimmune cerebellar ataxia. These include Yo Antibody, Voltage-Gated Calcium Channel (VGCC) Type P/Q Antibody, and Tissue Transglutaminase (tTG) Antibody (IgA). Detecting these antibodies can help pinpoint the underlying autoimmune process.

Understanding the results requires interpretation by a qualified healthcare professional. A positive result may indicate the presence of an autoimmune disorder affecting the cerebellum, guiding further management. A negative result may help rule out certain conditions but does not exclude all possibilities. Discussing your results with your doctor is essential for understanding their implications and determining the next steps in your care.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationOvernight fasting is preferred. A completed Test Send Out Consent Form (Form 35) is required.
Sample3 mL (1.5 mL minimum) serum collected in an SST tube.
MethodologyImmunoassay techniques are used to detect the presence of specific antibodies in the serum sample.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects specific antibodies associated with autoimmune cerebellar ataxia. A negative result does not rule out all autoimmune conditions or other causes of cerebellar symptoms. Confirmation with the laboratory before booking is advised.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Cerebellar ataxia is a neurological sign consisting of lack of voluntary coordination of muscle movements that can include gait abnormality, speech changes, and abnormalities in eye movements.
It occurs when the body's immune system mistakenly attacks cells in the cerebellum, the part of the brain controlling coordination and balance.
Symptoms can include problems with balance, walking, coordination, speech, and eye movements. Dizziness and frequent falls are also common.
This test helps identify specific antibodies linked to autoimmune cerebellar ataxia, aiding in diagnosis and guiding treatment decisions.
Overnight fasting is preferred for optimal results.
Results will be provided to the ordering physician. Please discuss the results and their meaning with your doctor.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp